← back to search

David V. Erbe

Johns Hopkins Medicine · US
Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research focused on Primary hyperoxaluria and Oxalate, with related work in Human serum albumin, Knockout mouse, Glyoxylate cycle. Notable publications include 'An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria', 'Crystal Structure of an HSA/FcRn Complex Reveals Recycling by Competitive Mimicry of HSA Ligands at a pH-Dependent Hydrophobic Interface', and 'Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1'.
h-index
citations
496
works
5
NIH funding
primary concept
email

Recent publications

Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1
Clinical Journal of the American Society of Nephrology 2021cited by 79position: middledoi
Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria
eLife 2020cited by 62position: middledoi
Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019cited by 42position: middledoi
An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria
Journal of the American Society of Nephrology 2016cited by 199position: middledoi
Crystal Structure of an HSA/FcRn Complex Reveals Recycling by Competitive Mimicry of HSA Ligands at a pH-Dependent Hydrophobic Interface
Structure 2013cited by 114position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tracy L. McGregor · Vanderbilt University2 papers (2020–2021)Patrick Haslett · Alnylam Pharmaceuticals (United States)2 papers (2016–2021)John Knight · University of Alabama at Birmingham2 papers (2016–2019) · 2 papers (2016–2019)John C. Lieske · Mayo Clinic2 papers (2020–2021)Ross P. Holmes · University of Alabama at Birmingham2 papers (2016–2019) · 1 papers (2013–2013)K. Dane Wittrup · Massachusetts Institute of Technology1 papers (2013–2013)Kevin Fitzgerald · Massachusetts Institute of Technology1 papers (2016–2016)Daniel G. MacArthur · Garvan Institute of Medical Research1 papers (2020–2020)Paul Nioi · Alnylam Pharmaceuticals (United States)1 papers (2020–2020)Chris Griffiths · Queen Mary University of London1 papers (2020–2020)Jaap W. Groothoff · Amsterdam Neuroscience1 papers (2021–2021)Brian R. Bettencourt · The University of Texas Southwestern Medical Center1 papers (2016–2016) · 1 papers (2021–2021) · 1 papers (2016–2016)William G. van’t Hoff · University of Amsterdam1 papers (2021–2021)David A. van Heel · Harvard University1 papers (2020–2020)Jiandong Lu · Guangzhou University of Chinese Medicine1 papers (2021–2021)Kyle D. Wood · University of Alabama at Birmingham1 papers (2019–2019)